Monday, August 9, 2010

Who was Mary Joseph ?

Mary Joseph was born on August 11-1925, she was a very kind, loving and hard working lady, all her life she gave to other so much of her time especially with sick people, she also gave freely to those who did not had food, clothes, shoes, medicines and more.

Mary did this for over fifty years of her life, helping people especially in the third world countries she would used her own personal money each week to buy foods, medicine, shoes, clothes and more, she would shop in Newark, Jersey City, Elizabeth, New Jersey and New York. Then every week end she would pack the boxes and send them off with a smiling face.

Mary had a joy on her face especially when she was packing the boxes to send to these people who did not had anything to eat and were sick.
Mary always believe God love a cheerful giver so she gave willingly to others.

In the late 1980 Mary saw her two cousins Willie and Fann came down with Alzheimer's and it really devastated her, then in early 1991 Mary came down with Alzheimer's until 1998 she die from the Alzheimer's disease.

In Alzheimer’s disease many studies show memory for old events are preserved till the advanced stages of the disease. In the early stages, the ability to learn new things are impaired. Since the common man assumes that memory for old events are more important, some individuals who have Alzheimer's disease is not brought to the doctor who specialize in treating Alzheimer's disease in the early stages of the disease.


Even if a individual with changes in intellectual capability is taken to a doctor, general physicians with limited experience in treating Alzheimer’s disease will rarely make a specific diagnosis of this disease. Although awareness is increasing, many misconceptions prevail among medical practitioners. Some family members continue to make this mistake.


Mary Joseph Foundation a non-profit international organization.
register with the Federal government and incorporated in the state of New Jersey
137 1/2 Washington Ave,
Belleville, New Jersey 07109

Some famous people who died from Alzheimer’s disease

In Alzheimer’s disease, memory for old events are preserved till the advanced stages of the disease. In the early stages, the ability to learn new things are impaired. Since the common man assumes that memory for old events are more important, some individuals who have Alzheimer's disease is not brought to the doctor in the early stages of the disease.

Even if a individual with changes in intellectual capability is taken to a doctor, general physicians with limited experience in treating Alzheimer’s disease will rarely make a specific diagnosis of this disease. Although awareness is increasing, many misconceptions prevail among medical practitioners.


Some famous people who died from Alzheimer’s disease


Adcock, Joe
baseball player


Astor Brooke
was an American philanthropist and socialite


Albertson, Mabel
actress


Andrews, Dana
actor


Balanchine, George
dancer, choreographer


Bing, Rudolph
opera impresario


Brooks, James
artist


Burrows, Abe
author


Chen, Joyce
chef


Copeland, Aaron
composer


DeKooning, Willem
artist


Dorsey, Thomas, A
father of gospel music


Fears, Tom
hall of fame professional football player and coach


Feraud, Louis
prominent fashion designer


Francis, Arlene
actress


Frankovich, Mike
movie producer


French, John Douglas
physician


Estelle Getty
actress

Goldwater, Barry
Arizona Senator


Heston Charlton
actor

Hayworth, Rita
actress


Henriquez, Raul Silva
Roman Catholic cardinal, human rights advocate


Joseph Mary
Mary Joseph Foundation

Klutznick, Philip
real estate developer, adviser to five U.S. Presidents


Leroy, Mervyn
director - 1987


Lord, Jack
actor


MacDonald, Ross
author


Meredith, Burgess
actor


Murdoch, Iris
author


O’Brien, Edmond
actor


O’Connell, Arthur
actor


Owen, Marv
baseball player


Picon, Molly
actress


Preminger, Otto
director


Quackenbush, Bill
hall of fame professional hockey player


Reagan, Ronald
former President of USA


Ritz, Harry
performer


Robinson, Sugar Ray
boxer


Rockwell, Norman
artist


Scott, Simon
actor


Shulman, Irving
screenwriter


Schwartz, Betty
first woman to win an Olympic gold medal in track events


Swift, Kay
composer


Van Vogt, Alfred
science fiction writer


White, E.B.
author


Wilson, Harold
British Prime Minister


Mary Joseph Foundation a non-profit international organization

Charlton Heston 1924-2008


Mary Joseph Foundation extends its deepest sympathies to the Heston family on the passing of Charlton Heston on Saturday, April 5. In 2002, Mr. Heston courageously announced to the public that he was suffering with symptoms consistent with Alzheimer’s disease.

Currently there are over 8 million Americans living with dementia/Alzheimer’s disease and that number is expected to grow to as many as 30 to 35 million by 2050. Alzheimer’s disease is the seventh leading cause of death in the United States and growing.

Researchers are close to developing accurate ways to diagnose and treat Alzheimer’s, but current Alzheimer's funding is nowhere near enough. Significantly increased federal funding for Alzheimer's research, education and care is imperative to reach the goal of a world without Alzheimer’s.

Estelle Getty Born: July 25, 1924 in New York City, New York Occupation: Actor: ... She played Sophia on Golden Girls from 1985 to 1992...We at the Mary Joseph Foundation are sorry to hear about Estelle Getty condition, for sometime now she had developed and been living with dementia and later coming down with Alzheimer's.

Brooke Astor (March 30, 1902 – August 13, 2007) was an American philanthropist and socialite who was the chairwoman of the Vincent Astor Foundation, in 2000 Brooke Astor was diagnosis by her doctor of having Alzheimer's disease...On August 13, 2007 she died from Alzheimer's.

Although there is no cure as yet for Alzheimer’s disease, a lot can be done to make the individuals with Alzheimer's disease more comfortable.

Learn more about Alzheimer:

http://www.maryjosephfoundation.blogspot.com/
www.marycharityfoundation.blogspot.com
Mary Joseph Foundation a non-profit organization for Alzheimer's disease.
137 1/2 Washington Ave,
Belleville, NJ 07109
Register with the Federal government and incorporated in the state of New Jersey.

Long-term care for Alzheimer's

There may come a time when it is too difficult for you to care for your loved one at home. As the disease progresses, your job will become increasingly difficult — despite a variety of community services — to the point where long-term residential care may be the most responsible option.

Making the decision

As you come to terms with residential care, you may grapple with feelings of guilt that you're abandoning the person. You may assume incorrectly that people who wind up in nursing homes were discarded by their families. But the truth is just the opposite. Most families exhaust every other option before resorting to this type of arrangement, and, contrary to popular belief, most families do stay connected to the individual and visit often. You can also draw comfort in knowing that there are an increasing number of good programs that specialize in care and treatment of people with Alzheimer's disease.

Better understanding for Alzheimer's patient care

There has been a shift in the general philosophy of caring for people with dementia. In the past, the general consensus was that they should be continually oriented to reality. For instance, if a person talked about visiting a sister who had died, the caregiver would remind the person what year it was and that the relative wasn't alive. Experts recommended responses like "No, I'm not your daughter, I'm your nurse."


Experts now believe that these efforts are futile and only frustrate the individual. Today, the preferred approach is to validate the person's feelings. For instance, responses like "You must really love her" to a man who talks about his dead wife, rather than, "She died 8 years ago," fosters emotional well-being. Repeated validation may also curb some behavior problems associated with frustration.


Resurrecting the patients remove frustration


There is also more of an attempt to resurrect what's left of the person's "self." In high-quality programs, caregivers try to understand each person's past interests and plan activities accordingly. If, for example, a person loved to dance, he or she may still derive considerable enjoyment from music and dance activities at a center.


In one case involving someone who had been a newspaper reporter most of his life, his caregivers set up a makeshift newsroom with a typewriter and assigned him the task of writing a newsletter for the center. He was able to enjoy this until typing became too frustrating. Although his caregivers eventually removed the typewriter, they still reinforced the idea that he was working in a newsroom. In another case, a caregiver arranged for several former stamp collectors in the assisted-living facility to see a stamp exhibit that was in town. Despite their disease, the caregiver said they seemed to thoroughly enjoy the experience.


Real facts


Over half of all individuals living in nursing homes have Alzheimer's disease or another dementia.


Evaluating a home for Alzheimer's patient


Keep in mind that not all specialized Alzheimer's care is equal. When you visit a home, try to determine what makes it unique.For up to date information on the wide variety of options available and how to evaluate them because the Alzheimer's patient may live for as long as 4 to 8 years and during that time the patient will gets worse in a regressive state, contact the Mary Joseph Foundation.


Please remember these


When you visit a facility, ask plenty of questions, such as these:

  • How is the program geared specifically for people with Alzheimer's disease?

  • Are the caregivers trained in the treatment of Alzheimer's?

  • Is it a homelike environment?

  • Are residents engaged in meaningful activities?

  • Does the facility incorporates design features that can be helpful to those with Alzheimer's, such as enhanced lighting, color-coded hallways, and plenty of walking room?

  • Is the environment safe? How secure is it for people who wander?

  • How would an upset resident be handled?

  • How many people live there? What's the ratio of staff members to residents?

  • Can medical care be given on site if needed? Who provides it? Skilled nurses? Visiting physicians?

  • What personal items can the resident bring?

  • Are skilled professionals — including registered nurses, licensed practical nurses, and certified nursing assistants — on duty at all times?

  • How long and often may family members visit?

  • What's the cost? Does the facility requires you to pay privately?

  • If the patient needs to change to Medicaid funding after a few years, will he or she be able to remain at the facility?

  • Under what circumstances would a resident be required to leave?

Remember the average cost today of long-term care is between $39,860 a year for an assisted-living facility and $82,095 a year for a private room in a nursing home, you'll have to investigate payment options.

Remember we are here to help.


http://www.maryjosephfoundation.blogspot.com/
www.marycharityfoundation.blogspot.com

Progressive memory loss.

This is the hallmark of Alzheimer's disease. Initially, only short-term memory is impaired, and the person merely seems forgetful. But because short-term memory is essential for absorbing new information, the impairment soon interferes with the ability to interact socially and perform one's work. Long-term memory may be retained longer, often in great detail, but it becomes fragmented as the disease progresses. Toward the final stage, people with Alzheimer's may be unable to recall their own names.

The cerebral cortex

The third level of the brain is the cerebral cortex, commonly called the "gray matter." The cerebral hemispheres contain two specialized regions, one dedicated to voluntary movement and one to processing sensory information. But most of the gray matter is the association cortex, which becomes progressively larger as animals move up the evolutionary ladder. The association cortex is the region of conscious thought: It is where you store memory and language skills, process information, and carry out creative thinking.

Inside the brain

Inside the brain

In Alzheimer's disease, brain cells die and neuronal connections wither in all parts of the brain, but especially in the hippocampus and the amygdala — important parts of the limbic system that coordinate memory storage and recall — and the cerebral cortex, the seat of higher-level thinking, memory, and language.

A micro view of the brain

Up close, the brain is a web of interconnecting cells called neurons. How these cells communicate and what happens when these cells die form the basis of our understanding of brain disease.

How brain cells communicate

The neuron is the brain's basic unit for processing information. The human brain contains an incredible number of neurons — about 100 billion, give or take 10 billion. The neuron is a unique cell in activity and appearance. It generates both electrical and chemical signals, making it able to communicate quickly with distant neurons. Instead of the compact shape typical of other cells in the body, the neuron is like an oak tree with giant branches stretched out. Each neuron has a body containing a nucleus, one long fiber called an axon, and many shorter branching fibers called dendrites.


The neuron is both a receiver and a transmitter. When a neuron receives a signal, it generates an electrical impulse. This impulse travels through the neuron and down the axon to its end (the axon terminal). The signal is then passed on to other neurons. Viewed under a microscope, neurons look like a dense forest of trees whose branches are so closely intertwined that they appear to touch. But when the details are highlighted with a silver stain, it is clear that each cell is separated from its neighbors by tiny gaps called synapses. Because the electrical signal cannot bridge this space, some other mechanism is required for a neuron to communicate with its neighbors. This is where the neuron's chemical signal comes in.


Stored in the axon terminal are chemical messengers called neurotransmitters. The electrical impulse opens tiny pores in the axon terminal, allowing a supply of neurotransmitters to flood into the synapse. The chemical then attaches to receptors on a neighboring neuron. What happens next depends on whether the neurotransmitter has an exciting or inhibiting effect on the neuron.

How nerve cells communicate

How nerve cells communicate
  1. Electrical signal travels down axon of neuron.

  2. Chemical neurotransmitter is released.

  3. Neurotransmitter binds to receptor site.

  4. Signal continues into new neuron.

  5. Reuptake occurs; neurotransmitter is transported back into the cell that released it.

An excitatory neurotransmitter passes the message on by creating an electrical impulse in the cell that receives it, and the process of electrical-to-chemical signaling is repeated. But if an impulse were to be transmitted to every neuron in the brain, the result would be chaos; much like a power surge can cause a short circuit, neurons firing all at once would cause a prolonged epileptic seizure. To safeguard against this happening, inhibitory neurotransmitters suppress communication to neighboring neurons.


Of the more than 20 chemical messengers discovered thus far, a few are fairly well understood. Several of them are involved in memory, including acetylcholine, serotonin, and dopamine. Many of these neurotransmitters have additional functions; for example, serotonin helps regulate sleep and sensory perception, while dopamine helps regulate movement.


As biological processes go, the speed of thought is rapid (although slow compared with a computer). Electrical impulses in some neurons reach speeds of nearly 200 mph, and transmission from cell to cell takes about a thousandth of a second. In addition, one nerve cell may have more than 1,000 synapses and, with a single impulse, can transmit simultaneously to all its neighbors.

Plaques and tangles

Plaques and tangles

The brains of Alzheimer's patients contain neurofibrillary tangles inside neurons and clumps of fibers called neuritic plaques outside of neurons. A set of enzymes, called secretases, in the neurons cause plaques to form. The secretases snip pieces from a large amyloid precursor protein (APP), leaving behind fragments of amyloid proteins that snarl and clump with the debris of dying neurons (pieces of dendrites). In contrast to the neuritic plaques, neurofibrillary tangles form within neurons and are composed of aggregates of a different protein known as tau.

Beta-amyloid is a peptide composed of approximately 40 amino acids. Research has shed light on the chemical process responsible for the formation and deposit of this sticky, starchlike protein in the brains of Alzheimer's patients. This understanding has prompted pharmaceutical companies to start manufacturing drugs to block the formation of amyloid deposits (see "Amyloid production blockers").


These tangles and plaques, first described by Alois Alzheimer in 1907, have been the main focus of research for decades, and for good reason: The worse the mental deterioration, the more amyloid and tangles are found in brain tissue. The prevailing view among neurologists used to be that these deposits caused the mental changes in Alzheimer's disease.


However, tangles and plaques are not unique to this condition. Some are found in other dementing disorders, and a few are scattered about in the brains of healthy middle-aged and elderly people. Some neuroscientists have wondered if these occasional deposits might explain the mild forgetfulness associated with normal aging, but studies have cast doubt on this theory.


Studies now indicate that dementia in Alzheimer's patients is caused by the shrinkage and death of neurons and synaptic loss, not by tangles and plaques themselves. However, according to the leading hypothesis, amyloid deposits play an early role by setting in motion a cascade of biochemical events that causes the cells to shrink and die.


With advances in technology enabling them to count neurons, neuroscientists were able to make this discovery by examining brain tissue from 10 people with normal brain function who died after age 60. All the samples contained about the same number of neurons in an area of the association cortex richly supplied with nerves from the sensory region. For the first time, scientists had a standard for defining how many neurons were "normal" in the human brain. Furthermore, this finding indicated that neuron loss was not a product of normal aging.


Next, the researchers compared the normal samples with brain tissue from 10 people with Alzheimer's and discovered, on average, a 41% reduction in the number of neurons. And the longer dementia had been present, the fewer neurons were found. There was also a correlation with neurofibrillary tangles: People with the greatest neuron loss had more tangles, about 95% of which were inside the remaining neurons. However, loss of neurons was dramatically greater than the number of tangles.


The researchers offered "housekeeping" as a possible explanation for this discrepancy: Molecules that clear away dead cells in the body eventually removed the tangles. When they counted neuritic plaques, the researchers found no relationship with either neuron loss or disease duration, reinforcing the view that neuronal dysfunction and death cause dementia. Although tangles and plaques are still considered the diagnostic hallmarks of Alzheimer's disease, synaptic loss and neuron death correlate best with dementia.


Experts also believe that decreased levels of the neurotransmitter acetylcholine, a chemical that bridges synapses between neurons that affect memory, also contribute to the memory loss of Alzheimer's disease. In the cortex and hippocampus, where this neurotransmitter is needed for memory and learning, the acetylcholine-producing neurons (called cholinergic neurons) are normally plentiful. But of the several types of neurons that can degenerate in Alzheimer's disease, the cholinergic neurons are especially hard hit. As acetylcholine production falls in the cortex and hippocampus, dementia becomes progressively worse. By the time someone with Alzheimer's disease dies, the cortex may have lost 90% of its acetylcholine.


Other neurotransmitter abnormalities may also be present. Reduced levels of serotonin and noradrenaline have been found in some people with Alzheimer's disease. Imbalances among these and other neurotransmitters could explain why some patients experience sensory disturbances, depression, sleep problems, aggressive behavior, and mood swings.


Mary Joseph Foundation

137 1/2 Washington Ave,

Belleville, New Jersey 07109

Tuesday, December 22, 2009

Who get's Alzheimer's and at what age.

Alzheimer's disease is a progressive condition that damages areas of the brain involved in memory, intelligence, judgment, language, and behavior. It is the most common form of mental decline, or dementia, in adults age around 40s, 50s 60s 70s, 80s and in some rear cases in individuals in their thirties.


Alzheimer's disease always gets worse over time, but the course of the disease varies from person to person. While some people lose the ability to do daily activities very early on, others may still be able to function relatively for little while longer.


Physicians are sometimes reluctant to discuss in much detail what the future holds for someone with Alzheimer's disease. Their reticence is understandable. It's impossible to predict exactly how the disease will affect an individual because the symptoms and rate of progression vary. Some people develop severe psychiatric problems; others do not. A symptom can show up early or not appear until much later.


For some people, the decline is slow and gradual or longer; others experience a rapidly downhill course that ends in death within three to five years. The symptoms are also influenced by the person's intellectual abilities before the illness sets in, and by other health problems, personality, coping skills, and family or other support.


Over time, Alzheimer's disease causes severe mental and functional problems and eventually results in death. There is no cure for Alzheimer's disease. However, much can be done, including medicines and behavioral modifications, to maintain the person's quality of life and to help the person stay active. Many people with Alzheimer's disease can be cared for, to find out more you can send us an email or call us.


Mary Joseph Foundation a non-profit international organization for Alzheimer's disease.

Register and incorporated in the state of New Jersey.

Thursday, October 15, 2009

New Report Says over 10 Million Americans Will soon Develop Alzheimer's disease

Every 22 seconds in the world and every 71 seconds in this country, someone is diagnosed with Alzheimer's disease, and a startling new report out today from the Alzheimer's Association predicts that one out of every eight baby boomers — or over 10 million Americans — is expected to develop the disease sometime in the near future. If new treatments are years away, is there anything you can do today that might prevent it?


Fran Hershkowitz's mother began losing her memory more than a decade ago, and now Fran, who is 63, worries if he might be next.


"It's frightening, too, to think that one day this is going to be me." the younger Hershkowitz said. Evidence shows that physical exercise may be the most effective remedy today to prevent Alzheimer's disease, and large health studies have shown that people who stay physically active are less likely to develop the disease. Scientists put that idea to the test. Researchers bred mice to develop the specific kind of plaque in the brain, as seen in Alzheimer's disease. Some mice were allowed to exercise, and some were not. The autopsy results were stunning.


The brains of sedentary mice were riddled with the harmful plaques, but the physically active mice had 50 to 80 percent less plaque. Further tests revealed that the mice who exercised produced twice as much of an enzyme in the brain that prevents plaque buildup. The exercise also produced twice as many tiny blood vessels in the brain to allow plaques to escape. "Moving plaques from the brain into the blood, so it's carried to those organs like the liver where it can be destroyed," said Professor Sangram S. Sisodia, a neuroscientist at the University of Chicago and lead investigator in the study. Population studies suggest any exercise that raises your heart rate for 30 to 45 minutes at least several times a week can lower your risk of Alzheimer's. And the more the exercise you get, the lower your risk. "Regular physical exercise is probably the best means we have of preventing Alzheimer's disease today," said Dr. Ronald Petersen, director of the Alzheimer's Research Center at the Mayo Clinic in Rochester, Minn.


"There are other possible intervention, including diet, and supplements, intellectual activities, but the data indicate that physical activity is the most likely to prevent this disease," Doctor William Thomas said. For family members determined to avoid another generation of this disease, there is finally preventative action they can take, which they won't have to wait for.


"Regular physical exercise is probably the best means we have of preventing Alzheimer's disease today." Dr. Ronald Petersen of the Mayo Clinic Alzheimer's Disease Research Center said. "Better than medications, better than intellectual activity, better than supplements and diet."


For family members determined to avoid another generation of this disease, there is finally preventative action they can take, which they won't have to wait for.


Mary Joseph Foundation a non-profit international organization for Alzheimer's disease.

Register and incorporated in the state of New Jersey.

Friday, October 2, 2009

Alois Alzheimer

Alois Alzheimer was born in 1864 in Markbreit in Bavaria, Southern Germany. Excelling in sciences at school he studied medicine in Berlin, Aschaffenburg Tubingen and Wurzburg where he graduated with a medical degree in 1887. He began work in the state asylum in Frankfurt am Main, becoming interested in research on the cortex of the human brain. Here he commenced his education in psychiatry and neuropathology.

Along with Franz Nissl, a colleague at the asylum, Alzheimer spent the following years working on a major six volume study, the 'Histologic and Histopathologic Studies of the Cerebral Cortex,' describing the pathology of the nervous system. The work was finally published between 1907 and 1918. In 1895 Alzheimer was appointed director of the asylum where he continued his research on a number of subjects including manic depression and schizophrenia.
Today, the pathological diagnosis of Alzheimer's disease is still generally based on the same investigative methods used in 1906. This is remarkable compared with the development of investigative methods for other diseases, and it speaks volumes about the quality of Alzheimer's discovery.

Alzheimer's disease is the most common cause of dementia and accounts for 65% - 80% of all cases. It destroys brain cells and nerves disrupting the transmitters which carry messages in the brain, particularly those responsible for storing memories. Alzheimer's disease was first described by A. Alzheimer's in 1906.


During the course of Alzheimer's disease, nerve cells die in particular regions of the brain. The brain shrinks as gaps develop in the temporal lobe and hippocampus, which are responsible for storing and retrieving new information. This in turn affects people's ability to remember, speak, think and make decisions. The production of certain chemicals in the brain, such as acetylcholine is also affected. It is not known what causes nerve cells to die but there are characteristic appearances of the brain after death. In particular, 'tangles' and 'plaques' made from protein fragments are observed under the microscope in damaged areas of brain. This confirms the diagnosis of Alzheimer's disease.


Currently there are over 30 million peoples worldwide who are living with Alzheimer’s disease and that number is expected to grow to well over 61 million by 2020. Alzheimer’s disease is the seventh leading cause of death in the United States and number six worldwide.


Mary Joseph Foundation a non-profit international organization for Alzheimer's disease.

register and incorporated in the state of New Jersey.

Mary Joseph Foundation
137 1/2 Washington Ave.
Belleville, New Jersey 07109